Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.

MLA

Kattan, Shahad W., et al. “Association of Cyclin-Dependent Kinase Inhibitor 2B Antisense RNA 1 Gene Expression and Rs2383207 Variant with Breast Cancer Risk and Survival.” Cellular & Molecular Biology Letters, vol. 26, no. 1, Apr. 2021, p. 14. EBSCOhost, https://doi.org/10.1186/s11658-021-00258-9.

APA

Kattan, S. W., Hobani, Y. H., Shaheen, S., Mokhtar, S. H., Hussein, M. H., Toraih, E. A., Fawzy, M. S., & Abdalla, H. A. (2021). Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival. Cellular & Molecular Biology Letters, 26(1), 14. https://doi.org/10.1186/s11658-021-00258-9

Chicago

Kattan, Shahad W, Yahya H Hobani, Sameerah Shaheen, Sara H Mokhtar, Mohammad H Hussein, Eman A Toraih, Manal S Fawzy, and Hussein Abdelaziz Abdalla. 2021. “Association of Cyclin-Dependent Kinase Inhibitor 2B Antisense RNA 1 Gene Expression and Rs2383207 Variant with Breast Cancer Risk and Survival.” Cellular & Molecular Biology Letters 26 (1): 14. doi:10.1186/s11658-021-00258-9.